Johnson & Johnson (NYSE:JNJ) ranks among the stocks to benefit from an onshoring boom. On July 23, Erste Group raised the ...

Johnson & Johnson (NYSE:JNJ) is one of the stocks that Jim Cramer shed light on. Cramer was incredibly bullish on the company ...

Johnson & Johnson N/A must pay more than US$42-million to a Massachusetts man who alleges that he developed mesothelioma, a ...

Johnson & Johnson MedTech (NYSE: JNJ) announced today that it launched its VirtuGuide AI-powered, patient-matched Lapidus ...

Tuesday, July 29, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc.

Biopharma giant Johnson & Johnson’s ($JNJ) stock hit new highs this year after reporting its Q2 results on July 16th, giving ...

Icotrokinra is designed to selectively block the IL-23 receptor, which drives inflammation in plaque psoriasis and ...

Sometimes you get these days where it feels like the market has returned to some semblance of what you’re used to when things ...

Johnson & Johnson (NYSE: JNJ) – Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, today ...

Johnson & Johnson (JNJ) stock in focus as Darzalex SC developed with Halozyme (HALO) and Genmab (GMAB) receives EU nod for ...

Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, ...

Early data from robust Autonomy Phase 2b posdinemab trial demonstrate Company's leadership in multimodal biomarkers and early detection New ...